In October 1998, a patient developed deep surgical-site and organ-space infection with Aspergillus fumigatus 11 days after undergoing liver retransplantation; subsequently, 2 additional patients in the transplant intensive care unit had invasive pulmonary infection with A. fumigatus diagnosed.
It was determined that debriding and dressing wounds infected with Aspergillus species may result in aerosolization of spores and airborne person-to-person transmission.
Aspergillus species are the most common causes of invasive mold infection worldwide, especially in severely immunosuppressed persons [1] [2] [3] [4] . Among solid-organ transplant recipients, the risk of invasive Aspergillus infection varies and often follows treatment for transplant rejection [1] . The majority of solid-organ transplant recipients with Aspergillus infection have pulmonary, rhinocerebral, or disseminated diseases. Surgical wound infection with Aspergillus species is relatively more common among liver transplant recipients than it is among persons who have received other transplants, and it may result from perioperative wound contamination due to prolonged operative duration, large operative site, and the net state of immunosuppression [1, 5, 6] .
The presence of Aspergillus species in the environment is the most important risk factor for nosocomial invasive aspergillosis, and outbreaks of infection have been associated with hospital construction or renovation activities, contaminated air-handling systems, and other environmental reservoirs [7] [8] [9] [10] . Inhalation and direct inoculation of tissue by spores are believed to be the most common routes of infection. Person-to-person transmission of Aspergillus species has not been reported elsewhere, with the exception of reports of direct donor-to-recipient transmission [11] . Here, we describe a cluster of pulmonary infections with Aspergillus fumigatus among liver transplant recipients in which wound care resulted in aerosolization of Aspergillus spores and probable person-to-person airborne transmission. Case reports. Patient 1 was a 53-year-old man who underwent orthotopic liver transplantation in September 1998 for alcoholic cirrhosis. His postoperative course was complicated. On day 2 of hospitalization, he underwent exploratory laparotomy, evacuation of an abdominal wall hematoma, and synthetic mesh closure of the abdominal fascia. On day 5 of hospitalization, he underwent repair of a bile leak. One day later, he underwent retransplantation, because of primary graft nonfunction, and reconstruction of the abdominal wall with synthetic mesh. He developed acute renal failure that required hemodialysis and reoperation for repair of vascular anastomotic bleeding on day 7. On day 17 of hospitalization, drainage from the large abdominal wound was noted, and culture of a drainage sample yielded A. fumigatus. The patient was transferred to the 11-bed transplant intensive care unit (ICU), where he was treated in an open cubicle. From day 18 to day 45 of hospitalization, intravenous amphotericin B was administered daily and wet-to-dry dressings were applied to the wound 3 times per day. Surgical debridement of abdominal wall and fascia for necrotizing infection was performed at the bedside on days 19, 22, and 27 of hospitalization. The patient died on day 45 of hospitalization of disseminated Aspergillus infection that involved the liver, spleen, omentum, and intestines (figure 1).
Patient 2 was a 61-year-old woman who underwent orthotopic liver transplantation in October 1998 for hepatitis C virus-associated cirrhosis. After undergoing transplantation, she was transferred to an open cubicle in the transplant ICU. On day 9 of hospitalization, the patient developed sepsis and respiratory failure. failure and aplastic anemia and died on day 22, with radiographic and microbiologic evidence of pulmonary aspergillosis. No autopsy was performed.
Methods. A case of aspergillosis in a liver transplant recipient was defined as (1) histopathologic evidence of tissue invasion consistent with Aspergillus species, (2) isolation of Aspergillus species from a normally sterile body site, or (3) isolation of Aspergillus species from у1 bronchoalveolar lavage fluid specimen or у2 respiratory specimens and clinical and radiographic abnormalities compatible with locally invasive or disseminated infection. Aspergillosis was considered to be nosocomial if Aspergillus species were first isolated from a patient after у7 days of hospitalization or within 30 days after hospital discharge.
To determine the rate of nosocomial aspergillosis, we reviewed the records for liver transplant recipients for the period of January 1997 through October 1998. Rates of definite and possible infection were calculated per 1000 patient days and were compared using the x 2 test. To examine potential sources of Aspergillus species in the transplant ICU, we placed Sabouraud dextrose agar settle plates within 1 m of patient beds for 30 min, and we also collected air samples for 30 min before and after wound dressing changes by use of a 2-stage viable particle sampler calibrated to sample air at a rate of 28.3 L/ min (Andersen Samplers).
Isolates of Aspergillus were identified by the morphologic characteristics of conidia and conidiophores [12] . Monoconidial isolates were obtained for each primary isolate of A. fumigatus by plating dilutions of conidia on Sabouraud dextrose agar plates. A single thallus was picked, transferred to Sabouraud dextrose agar slants, and incubated for 3 days at 37ЊC. Nonoutbreak isolates were obtained from the fungal culture collection maintained at the Mycotic Diseases Branch of the Centers for Disease Control and Prevention (Atlanta, Georgia) [13] . Cell growth and pulverization in liquid nitrogen were performed as described by Lin et al. [13] . Genomic DNA was purified using phenol-chloroform extractions or by resuspending nucleic acids in Qiagen QBT buffer and eluting DNA through a Qiagen Genomic G-100 tip, in accordance with the manufacture's recommendations [13] .
To determine the genetic relatedness across patient, environmental, and nonoutbreak isolates, EcoRI genomic blots were hybridized with the moderately repetitive DNA probe Afut1, which was kindly provided by Dr. D. Soll (University of Iowa, Iowa City) [14, 15] . Purified genomic DNA (3 mg) was digested with 25 units of EcoRI (Sigma) for 6 h at 37ЊC [16] . Samples were electrophoresed through 0.7% agarose gels in Tris-borate EDTA buffer, stained with 0.5 mg/mL of ethidium bromide, photographed, and then blotted to positively charged nylon filters (Roche Diagnostics) [16] . Nylon filters were hybridized overnight at 65ЊC with denatured Afut1 DNA probe labeled with digoxigen [15, 16] . Unbound probe was removed by washing at 65ЊC with 2 ϫ sodium chloride/0.1% sodium dodecyl sulfate twice for 30 min each. Hybridization bands were visualized using the reagents and protocol in the Genius kit (Roche Diagnostics). A Fluor-S-Multimager (Bio-Rad Labo- On the day when Aspergillus fumigatus was first isolated in patients 2 and 3, the 3 patients were located in bed E (patient 1), bed G (patient 3), and bed I (patient 2). Air supply ventilation panels were located above each bed (Ⅺ) and air exhaust panels in the central workstation (solid arrowheads) and in each private room. Placement of settle plates and A. fumigatus colony counts are indicated with dashed arrows. ratories) was used to scan the hybridization bands, and the image was digitized using Diversity Database software (BioRad). Strains were considered "identical" if there was no difference between the hybridization profiles; they were considered "highly related" if they differed by 1-3 bands; and they were considered "unrelated" if they differed by у4 bands. These interpretive criteria were more stringent than those used in other studies [17] .
Results. The transplant ICU consists of 8 open cubicles, which are separated by curtains, and 3 private rooms ( figure  2) . During the outbreak, 90% fresh and 10% recirculated air was supplied from ventilation panels located above each patient bed, and high-efficiency particulate air filtration was not performed; air exhaust ventilation panels were located at the central workstation and in each private room. Air pressure in the ICU was neutral with respect to the outside corridor. No hospital construction or maintenance to the hospital air-handling system was performed during the 3-month period before the outbreak, and no environmental reservoir of Aspergillus was identified by careful visual inspection of the unit and floor. During October 1998, the rate of nosocomial aspergillosis among patients on the liver transplant service was 10-fold higher than it was during the period of January 1997 through September 1998 (2. ). P p .007 Patient 1 was hospitalized in the transplant ICU in open cubicle C for 10 days and then in cubicle E for 9 days before A. fumigatus was first isolated from patients 2 and 3 (figure 2). During this 19-day period, 35 patients were treated in open cubicles in the unit, with a median duration of potential exposure to patient 1 of 2 days (range, 1-11 days). Of the 35 patients, 19 (55%) were cared for by the liver surgery service, with a median duration of exposure to patient 1 of 5 days. Patients 2 and 3 were treated in cubicles that were on the opposite side of the unit from that of patient 1 for 11 days and 7 days, respectively, before A. fumigatus isolates were first recovered from them.
On day 41 of hospitalization, settle plates placed next to patient 1 yielded 4 and 15 colonies of A. fumigatus, as compared with 0 colonies per plate on 4 settle plates placed elsewhere in the unit (figure 2). On day 42 of hospitalization, patient 1 was moved from an open cubicle to an adjacent private room (F) with neutral air pressure. Portable high-efficiency particulate air filtration units were placed inside and outside the room, and airflow was adjusted to exhaust 100% of the room air outdoors. On day 42, settle plates placed inside the room yielded no colonies of A. fumigatus before and 19 and 34 colonies after a wound dressing change. On day 44, air samples obtained outside of the room contained levels of A. fumigatus of 1.1 cfu/m 3 before and 106.8 cfu/m 3 after a dressing change.
On day 45 of hospitalization, patient 1 was transferred from the unit to a negative-pressure isolation room in another ICU, where he died later that day. Four days after the transfer of patient 1, and on 4 additional occasions during the 24 subsequent months, no colonies of A. fumigatus or of other Aspergillus species were isolated from air samples obtained in different locations in the unit. After the outbreak, from November 1998 through October 2000, the rate of nosocomial aspergillosis decreased 5-fold, to 0.46 cases per 1000 patient days (13 cases in 28,076 days). All 5 tissue isolates obtained from patient 1, all 8 isolates tested from settle plates and air samples from around patient 1, and 3 of 4 respiratory isolates obtained from patient 2 had an identical hybridization profile (figure 3). The fourth respiratory isolate recovered from patient 2, the respiratory isolate recovered from patient 3, and the control isolates that were not associated with the outbreak or that were stored in the Afut1 database each had unique hybridization profiles distinctly different from the hybridization profile associated with patient 1 and from one another.
Discussion. By use of molecular typing methods, we demonstrated probable patient-to-patient transmission of A. fumigatus from aerosolization of conidiophores associated with surgical dressing changes and wound debridement. However, we cannot exclude the possibility that patients 1 and 2 shared common exposure to an environmental source of Aspergillus species. Several molecular typing and epidemiologic findings strongly support person-to-person airborne transmission. lanes 1-8) , respiratory isolates recovered from patients 3 (lane 9) and 2 (lanes [10] [11] [12] , tissue isolates recovered from patient 1 (lanes [13] [14] [15] [16] , and control isolates provided by the Centers for Disease Control and Prevention (Atlanta, Georgia; lanes [17] [18] [19] .
First, patients 1 and 2 had temporally clustered infections associated with a unique A. fumigatus isolate with an identity that was established using the Afut1 restriction-fragment length polymorphism (RFLP) analysis [14, 15] . The Afut1 DNA probe, a 6.9-kb retrotransposon-like repeated DNA element, has been used for RFLP analysis for 12000 environmental or clinical isolates of A. fumigatus, and it has demonstrated a very high degree of discrimination and reproducibility [18] [19] [20] . Isolates with an identical Afut1 genotype are rare, occurring in only 3% of all strains, and they do not cluster geographically in the absence of a common source of exposure [18, 20, 21] . Second, of the 35 patients who had potential risk of infection, patient 2 had the longest duration of exposure to patient 1 (11 days). While it is speculative, the duration of exposure of patient 2 suggests that the incubation period for human aspergillosis is р11 days. Third, we demonstrated that changing dressings resulted in a 100-fold increase in the number of A. fumigatus spores aerosolized from the patient's abdominal wound. Finally, no other environmental source of Aspergillus species was identified in the transplant ICU during the outbreak or by surveillance air sampling, and during the subsequent 24 months, the rate of nosocomial aspergillosis returned to preoutbreak levels. Because clinical and environmental A. fumigatus isolates have been shown to be extremely genetically diverse with no observable clustering by geographic location, isolation of the same Afut1 genotype from both patients 1 and 2 is highly suggestive of nosocomial patient-to-patient transmission [20, 21] . To our knowledge, this is the first report of probable nosocomial patient-to-patient airborne transmission of Aspergillus species.
Patient 1 had multiple risk factors for invasive Aspergillus infection, including early retransplantation, prolonged cumulative operative time, acute renal failure, and enhanced immunosuppression [1, 6, 22] . The patient was probably exposed to a transient source of A. fumigatus in the transplant ICU or in other care areas during the 17 days before infection was detected. Baseline air samples obtained from the transplant ICU contained A. fumigatus spore counts (1.1 cfu/m 3 ) that were similar to those of unfiltered outdoor air in North America (0.2-3.5 cfu/m 3 ) [2] . After recognition of wound aspergillosis, patient 1 was placed in an open cubicle with an air supply ventilation panel located directly above the bed. The extent of the wound infection, frequent dressing changes, and repeated wound debridement likely resulted in periodic bursts of fungal spores from the patient's wound during the 19-day period before A. fumigatus was first isolated from patient 2. Although smoke testing was not performed, it is epidemiologically plausible that the centrally located air exhaust panel may have directed the aerosolized A. fumigatus spores from patient 1 across the unit to where patient 2 was hospitalized. Although 3 of the 4 strains of A. fumigatus isolated from patient 2 had a hybridization profile identical to that of patient 1, an isolate with a different Afut1 genotype and A. flavus-oryzae also were isolated from respiratory secretions of patient 2. This finding suggests that patient 2 was exposed to у1 additional source of Aspergillus species before or during the hospitalization. Infections with mixed Aspergillus species have been reported among patients with solidorgan transplants, aspergilloma, and cystic fibrosis [17, 23, 24] .
Because invasive diagnostic procedures were not performed, we cannot exclude the possibility that у1 of the Aspergillus strain types isolated from patient 2 were associated with colonization rather than pulmonary infection. A. fumigatus was, however, isolated from 3 different tracheal suction specimens obtained from this patient, and chest radiographs demonstrated progressive multilobar consolidation consistent with invasive pulmonary aspergillosis. Other patients undoubtedly were exposed to A. fumigatus spores from the index patient, but infection or colonization was not detected in these patients. We were unable to identify other significant risk factors for acquisition of the outbreak strain other than duration of exposure to patient 1 in the transplant ICU.
Although special air-handling, including high-efficiency particulate air filtration and positive room-air pressure relative to the corridor, is widely used to decrease the risk of nosocomial aspergillosis in high-risk bone marrow transplant recipients, it is less commonly used to protect patients who have received solid-organ transplants [25] [26] [27] [28] . In this investigation, we found that portable high-efficiency particulate air filtration without negative room-air pressure was ineffective in preventing the dissemination of spores outside of the index patient's room after a dressing change. After a dressing change, A. fumigatus spore counts obtained outside of the index patient's room were similar to those reported in other outbreaks of Aspergillus infection associated with construction activity or defective ventilation systems (106.8 cfu/m 3 vs. 2.3-133 cfu/m 3 , respectively) [2, 28] . Although the optimal placement of the portable highefficiency particulate air unit was not investigated, opening and closing the room door probably altered the room airflow and limited the effectiveness of air exhaust and filtration.
The results of this investigation emphasize that, in contrast to the tissue-invasive mycelial form, Aspergillus infection in the wound can sporulate in vivo and is potentially transmissible from person to person. Health care workers-especially those who treat immunocompromised patients-should be aware of this potential risk. Hospitalized patients with wound or cutaneous Aspergillus infection should have their lesions covered with a clean dressing and disruption minimized. If this is not feasible, the patient should be placed in a private room with monitored negative room-air pressure. The room door should be closed and high-efficiency filtration of room air considered. These recommendations should be considered for patients with tracheobronchial Aspergillus infection, which is a more common disease, especially among lung transplant recipients, for whom the potential for airborne transmission also may exist.
